← Leaderboards
Brian H. Johnstone
Indiana University Indianapolis
$1,471,193
Attributed
$2,308,724
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1M · FY2010–25$1M$750K$500K$250K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,308,724 · 5
By mechanism
R44$1,375,113 · 1
R43$803,252 · 3
S10$130,359 · 1
Top collaborators
- Subhrajit Saha2 shared
- Erik J Woods2 shared
Most similar at Indiana University Indianapolis
Same institution · by research overlap
- Sebastien Laulhe$1,548,409
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsIn VitroStem CellsPharmaceutical PreparationsBone MarrowMedicalIn VivoTransplantationSuccessBoneOrgan DonorAllogenicMajor Histocompatibility ComplexSafetyRegimenSourceEvaluationDoseCryopreservationProceduresInfectionHematopoietic Stem CellsMouse ModelLaboratories
Grant awards (7)
Developing a bank of purified myeloid progenitor cells as a bridging therapy for transient pancytopenia resulting from radiation injury$1,000,000
R44 · FY2025 · AI · contact PI
Developing a bank of purified myeloid progenitor cells as a bridging therapy for transient pancytopenia resulting from radiation injury$375,113
R44 · FY2024 · AI · contact PI
A Novel and Clinically Feasible Co-therapy of Deceased Donor Bone Marrow Combined With Donor-Matched Mesenchymal Stem Cells to Establish Immune Tolerance$142,485
R43 · FY2021 · AI · contact PI
Developing a bank of purified myeloid progenitor cells as a bridging therapy for transient pancytopenia resulting from radiation injury$299,998
R43 · FY2020 · AI · contact PI
A Novel and Clinically Feasible Co-therapy of Deceased Donor Bone Marrow Combined With Donor-Matched Mesenchymal Stem Cells to Establish Immune Tolerance$157,465
R43 · FY2020 · AI · contact PI
Validation of a Stroke Therapy Comprised of Synergistic Stem Cell-Derived Factors$203,304
R43 · FY2015 · NS · contact PI
Moor Vascular Assessment System -$130,359
S10 · FY2010 · RR · contact PI